Cite
HARVARD Citation
Nishihori, T. et al. (n.d.). An open‐label phase I/II study of cyclophosphamide, bortezomib, pegylated liposomal doxorubicin, and dexamethasone in newly diagnosed myeloma. European journal of haematology. pp. 426-435. [Online].